Reported Earlier, Tango Therapeutics Prices Upsized $600M Public Offering Of 18,166,667 Common Shares And 1,833,395 Pre-Funded Warrants At $30.00

Benzinga Newsdesk www.benzinga.com Neutral 89.3%